Personal information

PBPK, In Vitro In Vivo Extrapolation, Modeling and Simulation
United Kingdom

Activities

Employment (2)

Simcyp Ltd: Sheffield, South Yorkshire, GB

Employment
Source: Self-asserted source
Masoud Jamei

Certara UK: Sheffield, Sheffield, GB

2003-10-13 to present | Senior Vice President (Research and Development)
Employment
Source: Self-asserted source
Masoud Jamei

Works (15)

Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards

Clinical Pharmacokinetics
2025-01 | Journal article
Contributors: Ivan Tiryannik; Aki T. Heikkinen; Iain Gardner; Anthonia Onasanwo; Masoud Jamei; Thomas M. Polasek; Amin Rostami-Hodjegan
Source: check_circle
Crossref

Cytokine Dynamics in Action: A Mechanistic Approach to Assess Interleukin 6 Related Therapeutic Protein‐Drug–Disease Interactions

Clinical Pharmacology & Therapeutics
2025-01-14 | Journal article
Contributors: Xian Pan; Katherine L. Gill; Amita Pansari; Oliver Hatley; Liam Curry; Masoud Jamei; Iain Gardner
Source: check_circle
Crossref

Application of Physiologically Based Pharmacokinetic Model to Delineate the Impact of Aging and Renal Impairment on Ceftazidime Clearance

Antibiotics
2024-09-09 | Journal article
Contributors: Khaled Abduljalil; Iain Gardner; Masoud Jamei
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Physiologically Based Pharmacokinetic Model Relates the Subcutaneous Bioavailability of Monoclonal Antibodies to the Saturation of FcRn-Mediated Recycling in Injection-Site-Draining Lymph Nodes

Antibodies
2024-08-15 | Journal article
Contributors: Felix Stader; Cong Liu; Abdallah Derbalah; Hiroshi Momiji; Xian Pan; Iain Gardner; Masoud Jamei; Armin Sepp
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Incorporation and Performance Verification of Hepatic Portal Blood Flow Shunting in Minimal and Full PBPK Models of Liver Cirrhosis

Clinical Pharmacology & Therapeutics
2023-12 | Journal article
Contributors: Ben G. Small; Oliver Hatley; Masoud Jamei; Iain Gardner; Trevor N. Johnson
Source: check_circle
Crossref

Mechanistic Modeling of In Vitro Skin Permeation and Extrapolation to In Vivo for Topically Applied Metronidazole Drug Products Using a Physiologically Based Pharmacokinetic Model

Molecular Pharmaceutics
2022-09-05 | Journal article
Contributors: Sumit Arora; James Clarke; Eleftheria Tsakalozou; Priyanka Ghosh; Khondoker Alam; Jeffery E. Grice; Michael S. Roberts; Masoud Jamei; Sebastian Polak
Source: check_circle
Crossref

Non-specific binding of compounds in in vitro metabolism assays: a comparison of microsomal and hepatocyte binding in different species and an assessment of the accuracy of prediction models

Xenobiotica
2022-08-03 | Journal article
Contributors: Iain Gardner; Mandy Xu; Chunyan Han; Yi Wang; Xingjin Jiao; Masoud Jamei; Hiba Khalidi; Peter Kilford; Sibylle Neuhoff; Roz Southall et al.
Source: check_circle
Crossref

Population PBPK modeling using parametric and nonparametric methods of the Simcyp Simulator, and Bayesian samplers

CPT: Pharmacometrics & Systems Pharmacology
2022-06 | Journal article
Contributors: Janak R. Wedagedera; Anthonia Afuape; Siri Kalyan Chirumamilla; Hiroshi Momiji; Robert Leary; Mike Dunlavey; Richard Matthews; Khaled Abduljalil; Masoud Jamei; Frederic Y. Bois
Source: check_circle
Crossref

Development of physiologically‐based pharmacokinetic models for standard of care and newer tuberculosis drugs

CPT: Pharmacometrics & Systems Pharmacology
2021-11 | Journal article
Contributors: Helen Humphries; Lisa Almond; Alexander Berg; Iain Gardner; Oliver Hatley; Xian Pan; Ben Small; Mian Zhang; Masoud Jamei; Klaus Romero
Source: check_circle
Crossref

Mechanistic PBPK Modelling to Predict the Advantage of the Salt Form of a Drug When Dosed with Acid Reducing Agents

Pharmaceutics
2021-07-29 | Journal article
Contributors: Siri Kalyan Chirumamilla; Venkatesh Teja Banala; Masoud Jamei; David B. Turner
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Topical ocular pharmacokinetics and bioavailability for a cocktail of atenolol, timolol and betaxolol in rabbits

European Journal of Pharmaceutical Sciences
2020-12 | Journal article
Contributors: Anam Fayyaz; Veli-Pekka Ranta; Elisa Toropainen; Kati-Sisko Vellonen; Annika Valtari; Jooseppi Puranen; Marika Ruponen; Iain Gardner; Arto Urtti; Masoud Jamei et al.
Source: check_circle
Crossref

Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Predict the Impact of CYP2C9 Genetic Polymorphisms, Co-Medication and Formulation on the Pharmacokinetics and Pharmacodynamics of Flurbiprofen

Pharmaceutics
2020-11-02 | Journal article
Contributors: Ioannis Loisios-Konstantinidis; Rodrigo Cristofoletti; Masoud Jamei; David Turner; Jennifer Dressman
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed Physiologically-Based Pharmacokinetic Model of Ritonavir Norvir Tablet Absorption in Humans Under Fasted and Fed State Conditions

Molecular Pharmaceutics
2020-07-06 | Journal article
Contributors: Sumit Arora; Amita Pansari; Peter Kilford; Masoud Jamei; Iain Gardner; David B. Turner
Source: check_circle
Crossref

Ocular Intracameral Pharmacokinetics for a Cocktail of Timolol, Betaxolol, and Atenolol in Rabbits

Molecular Pharmaceutics
2020-01-09 | Journal article
Contributors: Anam Fayyaz; Veli-Pekka Ranta; Elisa Toropainen; Kati-Sisko Vellonen; Giuseppe D’Amico Ricci; Mika Reinisalo; Emma M. Heikkinen; Iain Gardner; Arto Urtti; Masoud Jamei et al.
Source: check_circle
Crossref

Developing Clinically Relevant Dissolution Specifications for Oral Drug Products—Industrial and Regulatory Perspectives

Pharmaceutics
2019-12 | Journal article | Author
Contributors: Mark McAllister; Talia Flanagan; Karin Boon; Xavier Pepin; Christophe Tistaert; Masoud Jamei; Andreas Abend; Evangelos Kotzagiorgis; Claire Mackie
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Peer review (3 reviews for 3 publications/grants)

Review activity for Clinical pharmacokinetics (1)
Review activity for Molecular pharmaceutics. (1)
Review activity for Pharmaceutical research. (1)